CD40 and lupus nephritis: In conclusion, our data strongly supports the potential therapeutic effects of selective CD40 blockade as a powerful form of immune deactivation in the inflamed kidney of animals with spontaneous autoimmune nephritis akin to human lupus nephritis, particularly when treatment is instituted during the early phases of the disease.